Skip links

Author: oncologs.com

Recent study reveals key immune cells as critical factors in lung cancer prognosis

(LOS ANGELES, July 30, 2024) – An extensive analytical study performed at the Terasaki Institute and published in Frontiers in Immunology highlights the crucial role of tissue-resident memory T cells and how they influence the immune environment of patients with non-small cell lung cancer and their overall prognosis. Credit:

(Epi)genetic aspects of metabolic syndrome pathogenesis in relation to brain-derived neurotrophic factor expression

Metabolic syndrome (MetS) is a multifaceted disorder that impacts approximately 20–25% of the global population. This syndrome encompasses a range of conditions, including obesity, type 2 diabetes mellitus, hyperinsulinemia, insulin resistance (IR), hypercholesterolemia, nonalcoholic fatty liver disease, nonalcoholic steatohepatitis, and systemic metabolic inflammation. These conditions

TGF-β and HIPPO signaling pathways interplay in distinct hepatic contexts

The liver’s ability to communicate with other organs is crucial for maintaining homeostasis, particularly through signaling pathways. During liver regeneration, communication with organs such as the brain, pancreas, intestine, and heart is vital, mediated by chemical messengers like hormones, cytokines, and growth factors. Among these
preclinical-study-explores-approved-drug-for-ovarian-cancer

Preclinical study explores approved drug for ovarian cancer

An iron-binding drug that is already approved for treatment of other diseases could provide a novel way to attack ovarian tumors, according to a new study led by Weill Cornell Medicine researchers. The preclinical study, which combined the analysis of human ovarian tumors and animal models
Explore
Drag